Department of Dermatology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM) (2025) Kalkavan H, Scheulen ME, Kämpgen E, Keilholz U, Heinzerling L, Lueong SS, Hlinka A, et al. Journal article Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis (2025) Röckel M, Musella L, Preusse C, Radke J, Zimmer L, Thoms KM, Dimitriou F, et al. Journal article Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction (2025) Fuchs K, D'Avanzo E, Armstark I, van Roey R, Clavel Ezquerra A, Bindel N, Siebenkäs K, et al. Journal article Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study (2025) Manger I, Schmitt C, Berking C, French LE, Vera González J, Heinzerling L Journal article The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche (2025) Wormser L, Fritz V, Kappelmann-Fenzl M, Rachinger N, Escudé P, Enderle K, Kaufmann M, et al. Journal article Special Issue “Molecular Advances in Cancer Immunotherapy” (2025) Schaft N Journal article Machine learning model to classify chronic leg wounds and identify pyoderma gangrenosum (2025) Busch DA, Richter ML, Hüsers J, Przysucha M, Kücking F, Mang JM, Moelleken M, et al. Journal article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients (2025) Ugurel S, Abu Rached N, Gambichler T, Mengoni M, Tüting T, Hassel JC, Reschke R, et al. Journal article